Importance of the group B streptococcus serotype V in materno-foetal infections;Place du streptocoque B serotype V dans les infections maternofoetales

Archives de Pediatrie

Volumn 4, Issue 11, 1997, Pages 1074-1078

  Le Thomas, I ^a   Lepercq, J ^a   Bergeret, M ^a   Francoual, C ^a   Raymond, J ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

Infant, newborn; Serotyping; Streptococcal infections; Streptococcus

Indexed keywords

ADULT; ANTIGEN SPECIFICITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLOOD CULTURE; DIAGNOSTIC TEST; FEMALE; FRANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INFECTION; RISK ASSESSMENT; SEROTYPING; STREPTOCOCCUS AGALACTIAE; CLASSIFICATION; DISEASE TRANSMISSION; MICROBIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PROSPECTIVE STUDY; STREPTOCOCCUS INFECTION;

FEMALE; HUMANS; INFANT, NEWBORN; PARIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 0031266559     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(97)88971-3     Document Type: Article

References (16)

1. Jelinkova J, Motlova J. Worldwide distribution of two new serotypes of group B streptococci: type IV and provisional type V. J Clin Microbiol 1985;21:361-2
2. Boyer KM, Gotoff SP. Prevention of early onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986,314:1665-9
3. Baker CJ. Vaccine prevention of group B streptococcal disease. Ann Pediatr 1993;22:711-4
4. Raymond J, Bergeret M, Francoual C, Chavigné J, Gendrel D. Neonatal infection with Streptococcus milleri. Eur Clin Microbiol Infect Dis 1995;14:799-801
5. e journée parisienne obstétrico-pédiatrique, 1994:71-9
6. Blumberg HM, Stephens DS, Modansky M et al. Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis 1996;173:365-73
7. Hervas JA, Gonzalez L, Gil J, Paoletti LC, Nadoff LC, Benedi VJ. Neonatal group B streptococcal infection in Mallorca. Spain Clin Infect Dis 1993;16:714-8
8. Harrison LH, Dwyer DM, Johnson JA. Emergence of serotype V group B streptococcal infection among infants and adults [Letter]. J Infect Dis 1995;171:513
9. Eykyn SJ, Young SEJ, Cookson BD. Increased community-acquired septicemic infection with group B streptococci in adults. Lancet 1991;338:446
10. Rench MA, Baker CJ. Neonatal sepsis caused by a new group B streptococcal serotype. J Pediatr 1993;112: 638-40
11. Greenberg DN, Ascher DP, Yoder BA, Heiman HS, Keith JF. Group B Streptococcus serotype V. J Pediatr 1993;123: 494-5
12. Adam MN, Le Pennec MP, Vandemeule-Broucke E, Giacomini T. Sérotypage du streptocoque du groupe B dans les prélèvements microbiologiques à l'hôpital Robert-Ballanger. Pathol Biol 1994;42:544-6
13. Gibbs RS, Hall RT, Yow MD, Mac Cracken GH, Nelson JD. Consensus: Perinatal prophylaxis for group B streptococcal infection. Pediatr Infect Dis J 1992;11:179-83
14. Heiman HS, Weisman LE. Transplacental or enteral transfer of maternal immunization-induced antibody protects suckling rats from type III Group B streptococcal infection. Pediatr Res 1989;26:629-32
15. Paoletti LC, Wessels MR, Rodewald AK, Shroff AA, Jennings HJ, Kasper DL. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide tetanus toxid conjugate vaccine. Infect Immun 1994;62:3236-43
16. Wessels MR, Paolotti LC, Pinel J, Kasper DL. Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxid conjugate vaccine. J Infect Dis 1995;171:879-84